News and Events

Melanomas often diagnosed in people with a limited number of moles

8 March 2016

“Physicians and patients should not rely on the total nevus count as a sole reason to perform skin examinations or to determine a patient’s at-risk status”, according to authors of a recent study. They also conclude “younger patients should be educated on the increased risk of thicker melanomas that is associated with having more atypical nevi”.

Three ways to know UVR levels in NZ

7 March 2016

There are now three different ways of knowing what current UV radiation levels are in New Zealand, where levels are monitored and measured by NIWA.

Dermatology Research Review: First issue for 2016

29 February 2016

This recently published Dermatology Research Review offers a varied and interesting selection of the latest research from around the globe, including four melanoma-related publications

Inherited genetic markers may predict melanoma survival

26 February 2016

Researchers have discovered an inherited genetic marker that might provide clinicians with a personalised tool to gauge an individual's survival and determine which patients require closer monitoring in the years following surgery.

Call for support of parliamentary petition

23 February 2016

Organisers of a petition on the availability of the drug pembrolizumab in New Zealand invite members of the public, especially those affected by metastatic melanoma and their clinicians, to take part in its presentation to parliament on Tuesday 1 March 2016 at 12.30 pm.

Report of Melanoma Summit 2015

23 February 2016

A recent Expert Forum publication features a superb report of selected presentations and workshop outcomes from the Melanoma Summit 2015 hosted by MelNet and the Health Promotion Agency on 6-7 November 2015.

Positive attitude towards melanoma recognition among osteopaths

11 February 2016

UK and Australian osteopaths have a positive attitude towards melanoma recognition, according to the results of a study published in the International Journal of Osteopathic Medicine. The authors recommend that future research should evaluate reliability of melanoma recognition rates by osteopaths using the "ugly duckling sign" versus osteopaths using rule-based approaches.